Tilray Brands (TLRY) Cash from Operations Growth (3y) (2022 - 2026)
Tilray Brands (TLRY) Cash from Operations Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.88 Bn | 87.01 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 34.90% |
| 3 | Zoetis | 32.31 Bn | 30.37 Bn | 1.62 Bn | -9.94% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -10.80% |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | 7.32% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn | -26.33% |
| 8 | Neurocrine Biosciences | 17.92 Bn | 16.61 Bn | 800.70 Mn | 46.81% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 27.85% |
| 10 | Tilray Brands | 446.76 Mn | 386.56 Mn | 54.95 Mn | -5.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -5.60% |
| Nov 30, 2025 | -31.85% |
| Aug 31, 2025 | 69.28% |
| May 31, 2025 | 14.55% |
| Feb 28, 2025 | 50.11% |
| Nov 30, 2024 | -33.49% |
| Aug 31, 2024 | 27.65% |
| May 31, 2024 | 54.98% |
| Nov 30, 2023 | -143.70% |
| Aug 31, 2023 | 34.39% |
| May 31, 2023 | -13.18% |
| May 31, 2022 | -9.55% |